Clovis Oncology reported $24.23M in Trade Creditors for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Agenus AGEN:US $ 41M 6.46M
Agios Pharmaceuticals AGIO:US $ 7.79M 3.76M
Anika Therapeutics ANIK:US $ 8.16M 0.72M
Arrowhead Research ARWR:US $ 5.89M 4.71M
Cerulean Pharma CERU:US $ 2.83M 727.79K
Clovis Oncology CLVS:US $ 24.23M 1.9M
Eli Lilly And LLY:US $ 1659.3M 226M
Enanta Pharmaceuticals ENTA:US $ 1.25M 4.74M
Esperion Therapeutics ESPR:US $ 12.83M 14M
Halozyme Therapeutics HALO:US $ 12.23M 10.97M
Heron Therapeutics HRTX:US $ 13.8M 5.58M
Insmed INSM:US $ 31.14M 17.43M
Intrexon XON:US $ 2.67M 1.75M
Ligand Pharmaceuticals LGND:US $ 19.15M 12.18M
Mirati Therapeutics MRTX:US $ 24.27M 3.67M
Novartis NOVN:VX 4.97B 114M
Puma Biotechnology PBYI:US $ 9.84M 2.43M
Rigel Pharmaceuticals RIGL:US $ 2.15M 2.46M
Sangamo Biosciences SGMO:US 13.08M 1.93M
Seattle Genetics SGEN:US $ 128.87M 41.64M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
Veracyte VCYT:US $ 10.33M 0.94M
YTE INCY:US $ 194.77M 42.22M